ArticleNature chemical biology2025
KLHL23 and RhoGDI coordinate CDC42 inactivation ensuring membrane homeostasis.
Article in Nature chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hearing loss associated with CDC42 in mice and humans (Takenouchi-Kosaki syndrome): CDC42 and RHOQ synergistically function in cochlear hair cells.The Journal of biological chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
F-Actin cytoskeleton remodeling is vital for cell migration, organ development and immune responses. The small GTPase CDC42, a key regulator of F-actin dynamics, cycles between inactive GDP- and active GTP-bound states. However, mechanisms governing CDC42 turnover and their biological significance remain unclear. Here we show that KLHL23-mediated polyubiquitylation of CDC42•GTP and RhoGDI-mediated sequestration of CDC42•GDP spatiotemporally co-inactivate CDC42, preserving membrane dynamics and homeostasis during migration. KLHL23-Cul3 acts as the E3 ligase for CDC42 degradation, with KLHL23 and RhoGDI competing for CDC42's switch II region, enhancing selectivity toward CDC42•GTP and CDC42•GDP, respectively. KLHL23 depletion disrupts membrane homeostasis, inducing excessive protrusions and promoting metastasis. Notably, the CDC42-Y64C germline variant in Takenouchi-Kosaki Syndrome escapes KLHL23-mediated degradation. Fluorescence resonance energy transfer assays reveal that KLHL23 and RhoGDI coordinately inactivate CDC42 in a spatiotemporal manner. These findings highlight the biological and clinical relevance of the KLHL23/RhoGDI-CDC42 axis, presenting new avenues for therapeutic exploration.
Identifiers
40846997What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.